ArticleOncotarget2016

MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.

Fuyumi Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.